Assetmark »

Nektar Therapeutics shares owned by Assetmark

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Assetmark from 13F filings

Historical chart of Assetmark investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Assetmark

Quarter filed Position value Share count Share price at filing
2024-03-31 $20 22 0.95
2019-03-31 $11k 325 33.85
2018-12-31 $12k 368 32.61
2017-12-31 $3.0k 51 58.82
2015-12-31 $0 19 0.00

More positions owned by Assetmark

Vanguard World Mega Grwth Ind (MGK)
Vanguard World Mega Cap Val Etf (MGV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Microsoft Corporation (MSFT)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Vanguard Index Fds Mcap Gr Idxvip (VOT)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr Core S&p500 Etf (IVV)
Spdr Ser Tr Bloomberg High Y (JNK)

View all positions for Assetmark

Top funds holding Nektar Therapeutics

Vanguard Group
Acadian Asset Management
PRIMECAP Management Company
BlackRock
Monaco Asset Management SAM
Citadel Advisors
Millennium Management
D. E. Shaw & Co
Nantahala Capital Management
Two Sigma Advisers
Two Sigma Investments
Shay Capital
Lynx1 Capital Management
Geode Capital Management
GSA Capital Partners

View all funds holding Nektar Therapeutics